Propranolol Relieves L-Dopa-Induced Dyskinesias in Parkinsonian Mice

被引：0
|
作者：
Shi, Z.
McKinley, J.
Bamford, I
Bamford, N.
机构：
来源：
ANNALS OF NEUROLOGY | 2018年 / 84卷
关键词：
Movement Disorders; Translational/Experimental Therapeutics;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
97
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [1] L-Dopa-Induced Dyskinesias are Reduced by Propranolol in Parkinsonian Mice
    Bamford, Nigel
    Shi, Ziqing
    Bamford, Ian
    Mckinley, Jonathan
    NEUROLOGY, 2019, 92 (15)
  • [2] Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
    Shi, Ziqing
    Bamford, Ian J.
    McKinley, Jonathan W.
    Devi, Suma Priya Sudarsana
    Vahedipour, Annie
    Bamford, Nigel S.
    BRAIN SCIENCES, 2020, 10 (12) : 1 - 17
  • [3] Role for α6 nicotinic receptors in L-dopa-induced dyskinesias in parkinsonian mice
    Quik, Maryka
    Park, Keon Min
    Hrachova, Maya
    Mallela, Archana
    Huang, Luping Z.
    McIntosh, J. Michael
    Grady, Sharon R.
    NEUROPHARMACOLOGY, 2012, 63 (03) : 450 - 459
  • [4] Clinical pharmacology of L-dopa-induced dyskinesias in Parkinsonian patients
    Rascol, O
    Brefel-Courbon, C
    Blin, O
    THERAPIE, 1998, 53 (01): : 43 - 48
  • [5] nAChR agonists reduce L-dopa-induced dyskinesias in parkinsonian rats
    Quik, M.
    Huang, L. Z.
    Lee, Y.
    Carroll, I. F.
    Parameswaran, N.
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (07) : 922 - 922
  • [6] Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With L-DOPA-Induced Dyskinesias
    Blandini, Fabio
    Bazzini, Eleonora
    Marino, Franca
    Saporiti, Federica
    Armentero, Marie-Therese
    Pacchetti, Claudio
    Zangaglia, Roberta
    Martignoni, Emilia
    Lecchini, Sergio
    Nappi, Giuseppe
    Cosentino, Marco
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 133 - 139
  • [7] Role of striatal ΔFosB in L-Dopa-induced dyskinesias of parkinsonian nonhuman primates
    Beck, Goichi
    Singh, Arun
    Zhang, Jie
    Potts, Lisa F.
    Woo, Jong-Min
    Park, Eun S.
    Mochizuki, Hideki
    Mouradian, M. Maral
    Papa, Stella M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (37) : 18664 - 18672
  • [8] Mirtazapine in L-dopa-induced dyskinesias
    Meco, G
    Fabrizio, E
    Di Rezze, S
    Alessandri, A
    Pratesi, L
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (04) : 179 - 181
  • [9] Pathophysiology of L-dopa-induced dyskinesias
    Bédard, PJ
    Blanchet, PJ
    Lévesque, D
    Soghomonian, JJ
    Grondin, R
    Morissette, M
    Goulet, M
    Calon, F
    Falardeau, P
    Gomez-Mancilla, B
    Doucet, JP
    Robertson, GS
    DiPaolo, T
    MOVEMENT DISORDERS, 1999, 14 : 4 - 8
  • [10] Mirtazapine in L-dopa-induced dyskinesias
    Fabrizio, E
    Vanacore, N
    Pratesi, L
    Di Rezze, S
    Alessandri, A
    Meco, G
    MOVEMENT DISORDERS, 2002, 17 : S107 - S107
12345